Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davis R Ingram

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Cancer Research|January 23, 2014
Universal marker and detection tool for human sarcoma circulating tumor cellsArun Satelli, Abhisek Mitra, Jeffry J Cutrera, et al.
Cancer Research|June 25, 2017
NF1<sup>+/-</sup> Hematopoietic Cells Accelerate Malignant Peripheral Nerve Sheath Tumor Development without Altering Chemotherapy ResponseRebecca D Dodd, Chang-Lung Lee, Tess Overton, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 22, 2014
NY-ESO-1 (CTAG1B) expression in mesenchymal tumorsMakoto Endo, Marieke A de Graaff, Davis R Ingram, et al.
Molecular Cell|April 7, 2022
The FUS::DDIT3 fusion oncoprotein inhibits BAF complex targeting and activity in myxoid liposarcomaHayley J Zullow, Akshay Sankar, Davis R Ingram, et al.
Archives of Pathology & Laboratory Medicine|October 14, 2020
Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentiginous Melanoma Than in Other Types of Cutaneous MelanomaWoo Cheal Cho, Wei-Lien Wang, Denái R Milton, et al.
Cancer Biology & Therapy|November 4, 2017
Co-targeting PI3K, mTOR, and IGF1R with small molecule inhibitors for treating undifferentiated pleomorphic sarcomaCaitlin D May, Sharon M Landers, Svetlana Bolshakov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2026
Validation of a seven-gene predictive SIGNature for the efficacy of Immuno-Oncology PD-1 inhibitors in patients with Sarcoma (SIGNIOS)David S Moura, Jesus Lopez-Marti, Hussein Tawbi, et al.
Cold Spring Harbor Molecular Case Studies|April 4, 2018
Genomic profiling of dedifferentiated liposarcoma compared to matched well-differentiated liposarcoma reveals higher genomic complexity and a common originHannah C Beird, Chia-Chin Wu, Davis R Ingram, et al.
Cancers|May 18, 2019
MAGE-A3 is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/MyxofibrosarcomaAnthony P Conley, Wei-Lien Wang, John A Livingston, et al.
Annals of Surgical Oncology|February 6, 2016
Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic SarcomaChristina L Roland, Caitlin D May, Kelsey L Watson, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Cancer Research|January 23, 2014
Universal marker and detection tool for human sarcoma circulating tumor cellsArun Satelli, Abhisek Mitra, Jeffry J Cutrera, et al.
Cancer Research|June 25, 2017
NF1<sup>+/-</sup> Hematopoietic Cells Accelerate Malignant Peripheral Nerve Sheath Tumor Development without Altering Chemotherapy ResponseRebecca D Dodd, Chang-Lung Lee, Tess Overton, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 22, 2014
NY-ESO-1 (CTAG1B) expression in mesenchymal tumorsMakoto Endo, Marieke A de Graaff, Davis R Ingram, et al.
Molecular Cell|April 7, 2022
The FUS::DDIT3 fusion oncoprotein inhibits BAF complex targeting and activity in myxoid liposarcomaHayley J Zullow, Akshay Sankar, Davis R Ingram, et al.
Archives of Pathology & Laboratory Medicine|October 14, 2020
Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentiginous Melanoma Than in Other Types of Cutaneous MelanomaWoo Cheal Cho, Wei-Lien Wang, Denái R Milton, et al.
Cancer Biology & Therapy|November 4, 2017
Co-targeting PI3K, mTOR, and IGF1R with small molecule inhibitors for treating undifferentiated pleomorphic sarcomaCaitlin D May, Sharon M Landers, Svetlana Bolshakov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2026
Validation of a seven-gene predictive SIGNature for the efficacy of Immuno-Oncology PD-1 inhibitors in patients with Sarcoma (SIGNIOS)David S Moura, Jesus Lopez-Marti, Hussein Tawbi, et al.
Cold Spring Harbor Molecular Case Studies|April 4, 2018
Genomic profiling of dedifferentiated liposarcoma compared to matched well-differentiated liposarcoma reveals higher genomic complexity and a common originHannah C Beird, Chia-Chin Wu, Davis R Ingram, et al.
Cancers|May 18, 2019
MAGE-A3 is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/MyxofibrosarcomaAnthony P Conley, Wei-Lien Wang, John A Livingston, et al.
Annals of Surgical Oncology|February 6, 2016
Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic SarcomaChristina L Roland, Caitlin D May, Kelsey L Watson, et al.
Pageof 6